YLC Event – Is the Gig Up? Why Independent Contractors and the Companies Who Use Them Should Worry

October 1, 2019
590 Sutter Street, San Francisco, CA, USA
150320221647327648

Join subject matter experts from the San Francisco Chronicle, California Chamber of Commerce, and more for a panel discussion about the gig economy and how independent contractors will be impacted by California Assembly Bill 5. Drinks and appetizers will be served. Doors open at 5:30 p.m. and the panel discussion begins at 6:15 p.m. Audience members will have the opportunity to ask questions and meet panel participants after the discussion.

 

Panel:

  • Jennifer Barrera, Executive Vice President, Cal Chamber

  • Carolyn Said, Business and Technology Reporter, San Francisco Chronicle

  • Shawn Lewis, Policy Director, National Federation of Independent Business  CA

  • Vignesh Ganapathy, Head of Government Relations,  Postmates

 

TuesdayOctober 1
5:30–7:30 p.m.

 

Neyborly
590 Sutter Street
Union Square, San Francisco

 

 

(function(d, s) {
var js, el = d.getElementsByTagName(s)[0];
window.BB_REG_FORM_ID = “c1ffd8d9-2971-4075-bdac-d813c3f0100c”;
window.BB_REG_FORM_ENVIRONMENT_ID = “p-VFwaa-F3ZU6uSLzlD1sBnw”;
js = d.createElement(s);
js.src = “https://sky.blackbaudcdn.net/skyuxapps/registration-form/assets/online_registrations_form_loader_v1.f8744b9a2e1826070a839886cbb55c9de563274d.js”;
el.parentNode.insertBefore(js, el);
})(document, “script”);

Tell Your Friends

Related

Health pina messina kfJkpeI6Lgc unsplash

Read part 3 of a series on drug pricing

Regulations, Not Anticompetitive Actions, Are Obstructing Drug Competition

The flaws driving up costs across the broader health care landscape are also driving up the costs for innovative drugs. After all, pharmaceuticals are an ...

America Doesn’t Have Enough Doctors. Medicare Is Making That Worse.

The United States is facing a shortage of 37,000 physicians, according to the latest research from the Association of American Medical Colleges. That deficit will ...
Prescription

How Price Controls Make a Healthy Drug Market Sick

The unspoken assumption behind the prescription drug price controls at the heart of the Democrats’ August 2022 Inflation Reduction Act (IRA) is that the pharmaceutical ...
Scroll to Top